Patent · US Active

Method for producing CD4/CD8 double-positive T cells

US11578310B2 · kind B2 · utility

2Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 21, 2017
Grant dateFeb 14, 2023
Priority date
Expiry dateApr 14, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for producing CD4/CD8 double-positive T cells, comprising the steps of: (1) culturing pluripotent stem cells in a medium to induce hematopoietic progenitor cells; and (2) culturing the hematopoietic progenitor cells obtained in the step (1) in a medium containing a p38 inhibitor and/or SDF-1 to induce CD4/CD8 double-positive T cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.